Abrdn PLC Arrowhead Pharmaceuticals, Inc. Transaction History
Abrdn PLC
- $57.3 Billion
- Q2 2025
A detailed history of Abrdn PLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Abrdn PLC holds 960,245 shares of ARWR stock, worth $36.9 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
960,245
Previous 1,072,827
10.49%
Holding current value
$36.9 Million
Previous $13.7 Million
11.0%
% of portfolio
0.03%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding ARWR
# of Institutions
325Shares Held
99.7MCall Options Held
444KPut Options Held
568K-
Black Rock Inc. New York, NY15.7MShares$603 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.5MShares$597 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.6MShares$408 Million3.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$245 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$201 Million1.65% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $4.07B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...